162 related articles for article (PubMed ID: 32272830)
21. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
22. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.
Zhuang L; Zhang B; Liu X; Lin L; Wang L; Hong Z; Chen J
Cell Biol Int; 2021 Oct; 45(10):2140-2149. PubMed ID: 34288231
[TBL] [Abstract][Full Text] [Related]
23. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation miR-146a-5p in Schwann cell-derived exosomes induced macrophage M1 polarization by impairing the inhibition on TRAF6/NF-κB pathway after peripheral nerve injury.
Sun J; Liao Z; Li Z; Li H; Wu Z; Chen C; Wang H
Exp Neurol; 2023 Apr; 362():114295. PubMed ID: 36493861
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
Li H; Zhu X; Zhang Y; Xiang J; Chen H
J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237
[TBL] [Abstract][Full Text] [Related]
26. M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice.
Qian B; Yang Y; Tang N; Wang J; Sun P; Yang N; Chen F; Wu T; Sun T; Li Y; Chang X; Zhu Y; Zhang Y; Han X
Diabetologia; 2021 Sep; 64(9):2037-2051. PubMed ID: 34117507
[TBL] [Abstract][Full Text] [Related]
27. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.
Ju X; Yu H; Liang D; Jiang T; Liu Y; Chen L; Dong Q; Liu X
Biomed Pharmacother; 2018 Jun; 102():549-554. PubMed ID: 29597088
[TBL] [Abstract][Full Text] [Related]
28. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
29. Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways.
Yu S; Gong LS; Li NF; Pan YF; Zhang L
Biomed Pharmacother; 2018 Jan; 97():213-224. PubMed ID: 29091869
[TBL] [Abstract][Full Text] [Related]
30. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
31. Effects of Holothurian Glycosaminoglycan on the Sensitivity of Lung Cancer to Chemotherapy.
Lin C; Zhu X; Jin Q; Sui A; Li J; Shen L
Integr Cancer Ther; 2020; 19():1534735420911430. PubMed ID: 32202167
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-reoxygenation induces macrophage polarization and causes the release of exosomal miR-29a to mediate cardiomyocyte pyroptosis.
Wang Y; Qiu Z; Yuan J; Li C; Zhao R; Liu W; Deng W; Gu N; Zhang W; Hu S; Bai Z; Shi B
In Vitro Cell Dev Biol Anim; 2021 Jan; 57(1):30-41. PubMed ID: 33420578
[TBL] [Abstract][Full Text] [Related]
33. Exosomes derived from cardiac parasympathetic ganglionic neurons inhibit apoptosis in hyperglycemic cardiomyoblasts.
Singla R; Garner KH; Samsam M; Cheng Z; Singla DK
Mol Cell Biochem; 2019 Dec; 462(1-2):1-10. PubMed ID: 31468244
[TBL] [Abstract][Full Text] [Related]
34. Effect of MiR-210 on the Chemosensitivity of Breast Cancer by Regulating JAK-STAT Signaling Pathway.
Xing Z; Wang X; Liu J; Liu G; Zhang M; Feng K; Wang X
Biomed Res Int; 2021; 2021():7703159. PubMed ID: 34423038
[TBL] [Abstract][Full Text] [Related]
35.
Liu G; Luo Y; Hou P
Immunol Invest; 2022 Jul; 51(5):1423-1436. PubMed ID: 34251965
[TBL] [Abstract][Full Text] [Related]
36. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.
Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effects of PLGA nanoparticles encapsulating the human PNAS-4 gene combined with cisplatin in ovarian cancer.
Qi X; Song X; Liu P; Yi T; Li S; Xie C; Zheng Y; Bai Y; Sun C; Wei Y; Zhao X
Oncol Rep; 2011 Sep; 26(3):703-10. PubMed ID: 21667029
[TBL] [Abstract][Full Text] [Related]
38. Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis.
Wang X; Huang R; Lu Z; Wang Z; Chen X; Huang D
Cancer Sci; 2022 Mar; 113(3):986-1001. PubMed ID: 35092121
[TBL] [Abstract][Full Text] [Related]
39. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells].
Zhang J; Bai HJ
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1062-1068. PubMed ID: 34695896
[No Abstract] [Full Text] [Related]
40. Cancer-associated fibroblasts-derived exosomes from chemoresistant patients regulate cisplatin resistance and angiogenesis by delivering VEGFA in colorectal cancer.
Shi Y; Zhu H; Jiang H; Yue H; Yuan F; Wang F
Anticancer Drugs; 2023 Mar; 34(3):422-430. PubMed ID: 36730310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
